Levofloxacin Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacin Fresenius Kabi, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It is employed to treat a broad spectrum of serious bacterial infections in adult patients, including respiratory, urinary, and soft‑tissue infections. The drug is indicated for both community‑acquired and hospital‑acquired infections, providing clinicians with a potent option when oral therapy is unsuitable.

GNH USA supplies Levofloxacin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics that require reliable intravenous antibiotic solutions worldwide.

Levofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections affecting various organ systems.

Community‑acquired pneumonia: rapid bacterial clearance leading to clinical improvement. Hospital‑acquired pneumonia: eradication of resistant Gram‑negative pathogens. Complicated urinary tract infections: resolution of infection and prevention of recurrence. Skin and soft tissue infections: reduction of cellulitis and wound infection signs. Intra‑abdominal infections: control of polymicrobial abdominal sepsis. Prostatitis: elimination of causative organisms and symptom relief.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensation.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis requiring medical attention.

When prescribing Levofloxacin, clinicians should consider several safety precautions.

Renal impairment: adjust dose based on renal function. History of tendon disorders: avoid use due to risk of tendon rupture. QT prolongation risk: monitor ECG in patients with cardiac arrhythmias. Concurrent use with antacids or multivitamins: separate administration by at least 2 hours. Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with other medicines, altering effectiveness or increasing toxicity.

Major Interactions (Avoid): - Other fluoroquinolones (e.g., ciprofloxacin): additive toxicity; avoid concurrent use. - Warfarin: increased anticoagulant effect; monitor INR closely. - Theophylline: increased plasma levels; risk of seizures.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate dosing. - NSAIDs: may increase risk of central nervous system stimulation. - Diabetes medications (insulin, sulfonylureas): may cause hypoglycemia; monitor glucose levels.